Skip to main content

Advertisement

Table 6 Phenotypes across sleep apnea severity categories

From: Distinct polysomnographic and ECG-spectrographic phenotypes embedded within obstructive sleep apnea

Phenotype across apnea severity categories Mild Moderate Severe Extreme Chi2, p, for phenotypes across categories
Chemoreflex phenotype—PSG (CAI ≥ 5/hour of sleep) 0 (0%) 1 (0.25%) 13 (4.1%) 15 (8%) 44.86,
<0.001
Chemoreflex phenotype—spectrogram (e-LFCNB present) 4 (7.4%) 70 (23.7%) 75 (23.4%) 67 (35.6%) 4.83,
0.19
Sleep fragmentation phenotype—sleep efficiency ≤ 70% 13 (18.6%) 82 (20.8%) 53 (16.6%) 48 (25.5%) 6.16,
0.10
Sleep fragmentation phenotype—N1 ≥ 30% 3 (4.3%) 24 (6.1%) 45 (14.1%) 76 (40.4%) 124.78,
<0.001
Sleep fragmentation phenotype—WASO ≥ 60 min 38
(54.3%)
240
(60.9%)
196
(61.3%)
136
(72.3%)
10.42,
0.02
Sleep fragmentation phenotype—spectrogram (HFC ≤ 30%) 9 (16.7%) 75 (25.3%) 80 (38.3%) 79 (70.5%)  
Sleep consolidation phenotype—sleep efficiency ≥ 90% 22 (31.4%) 76 (19.3%) 55 (17.2%) 27 (14.4%) 9.89,
0.02
Sleep consolidation phenotype—N1 ≤ 10% 42 (60%) 157 (39.9%) 85 (26.6%) 33 (17.6%) 58.01,
<0.001
Sleep consolidation phenotype—WASO ≤ 30 min 15
21.4%)
57
(14.5%)
34
(10.6%)
15
(8%)
11.08,
0.01
Sleep consolidation phenotype—spectrogram (HFC ≥ 50%) 28 (51.9%) 126 (42.6%) 61 (29.2%) 15 (12.3%) 2.46,
0.48
  1. WASO wake after sleep onset; N1 stage 1 NREM sleep; CAI central apnea index; HFC high frequency coupling; LFC low frequency coupling; e-LFC NB narrow band e-LFC